Download PDF
1 / Pages

Other users also viewed these articles

The benefits of measuring the size and number of lipoprotein particles for cardiovascular risk prediction: A systematic review and meta-analysis Jose A. Quesada; Vicente Bertomeu-González; Domingo Orozco-Beltrán; Alberto Cordero; Vicente F. Gil-Guillén; Adriana López-Pineda; Rauf Nouni-García; Concepción Carratalá-Munuera;
Clin Investig Arterioscler. 2023;35:165-77
Consensus document for lipid profile determination and reporting in Spanish clinical laboratories Teresa Arrobas Velilla; Carlos Guijarro; Raquel Campuzano Ruiz; Manuel Rodríguez Piñero; José Francisco Valderrama Marcos; Antonio Pérez Pérez; Manuel Antonio Botana López; Ana Morais López; José Antonio García Donaire; Juan Carlos Obaya; Luis Castilla Guerra; Vicente Pallares Carratalá; Isabel Egocheaga Cabello; Mercedes Salgueira Lazo; María Mar Castellanos Rodrigo; José María Mostaza Prieto; Juan José Gómez Doblas; Antonio Buño Soto;
Clin Investig Arterioscler. 2023;35:91-100
Triglycerides, HDL cholesterol and atherogenic dyslipidaemia in the 2019 European guidelines for the management of dyslipidaemias Juan Pedro-Botet; Juan F. Ascaso; Mariano Blasco; Ángel Brea; Ángel Díaz; Antonio Hernández-Mijares; Xavier Pintó; Jesús Millán;
Clin Investig Arterioscler. 2020;32:209-18